People often describe this as one of the more bothersome symptoms of nasal polyps. Nasal polyps can cause pain and pressure in the face or sinuses. In some cases, a person may feel pain and ...

The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.

GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population.

GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...

GSK's depemokimab met key endpoints in phase 3 trials for chronic rhinosinusitis with nasal polyps (CRSwNP), showing promise ...

If nasal congestion persists, pus can accumulate in the sinuses and inflammation can spread If inflammation continues, polyps can also develop in the sinuses I thought, if this continues ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been ...

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

Harvard Medical School scientists at Brigham and Women’s Hospital have designed a drug-free nasal spray that coats the inner ...

Some essential oils may clear up nasal passages and relieve sinus pressure and other congestion symptoms. Sinus congestion is uncomfortable to say the least. It may make it difficult for you to ...

But, for the first time, injecting epinephrine isn’t the only option. A San Diego-based company, ARS Pharmaceuticals, has ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...